ARCHIVES

First Panel Meeting On Centers Generates Possible Recommendations For Core Grant Guideline Changes

This article is from The Cancer Letter archive.

Vol. 10 No. 14 | April 6, 1984

Download PDF Visit The Full Archive

Related Articles

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

February 17, 2012

NCI Clinical Trials Enrollment Drops to 17,500

February 21, 2014

Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says

August 27, 2004

AMC Cancer Center, Rose Cancer Program Name Douglass Tormey Director; ECG Plans Move To Denver

September 4, 1992

UICC Fellowship, Exchange Programs

July 5, 1985

FDA Advisors Okay DDC For AIDS Treatment In Comb With AZT

May 8, 1992